2008 Annual Meeting
Session: Scale-up Issues in Pharmaceutical Formulation Development
This session is devoted to the implementation of novel approaches taken to address challenging scale-up issues related to the pharmaceutical industry. Of particular interest would be the discussion of laboratory and pilot-scale work performed to define the critical aspects of the chemical synthesis and/or drug product manufacture and the corresponding approaches to their implementation at larger scales.
Chair
Michael B. Mackaplow, Abbott Laboratories
Co-Chair
Mayur Lodaya, GlaxoSmithKline